Clinical Trial Update: Sexual Penetration Pain in Postmenopausal Women: A Topical Botanical Drug Treatment [Phase 2]

View source ↗

Summary

Phase 2 trial update for a topical botanical drug targeting sexual penetration pain in postmenopausal women; study terminated with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Arousal Disorders Sexual
• Dyspareunia
• Female Sexual Arousal Disorder
• Female Sexual Dysfunction
• Genito-pelvic Pain Penetration Disorder
• Postmenopausal Symptoms
• Sexual Pain Disorders
• Vestibulodynia
• Vulvodynia
• Vulvovaginal Atrophy

Drugs mentioned

• Topical botanical drug treatment (unnamed in snippet)

Snippet

Sponsor: GTO Pharmaceutical, LLC | Conditions: Sexual Pain Disorders, Postmenopausal Symptoms | Phase 2 | Status: TERMINATED | Results posted: 2022-06-28